These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 9496886

  • 1. Reduction of nitroarylmethyl quaternary ammonium prodrugs of mechlorethamine by radiation.
    Wilson WR, Ferry DM, Tercel M, Anderson RF, Denny WA.
    Radiat Res; 1998 Mar; 149(3):237-45. PubMed ID: 9496886
    [Abstract] [Full Text] [Related]

  • 2. Pathways of reductive fragmentation of heterocyclic nitroarylmethyl quaternary ammonium prodrugs of mechlorethamine.
    Kriste AG, Tercel M, Anderson RF, Ferry DM, Wilson WR.
    Radiat Res; 2002 Dec; 158(6):753-62. PubMed ID: 12452778
    [Abstract] [Full Text] [Related]

  • 3. Hypoxia-selective antitumor agents. 12. Nitrobenzyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine.
    Tercel M, Wilson WR, Anderson RF, Denny WA.
    J Med Chem; 1996 Mar 01; 39(5):1084-94. PubMed ID: 8676343
    [Abstract] [Full Text] [Related]

  • 4. Hypoxia-selective antitumor agents. 16. Nitroarylmethyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine.
    Tercel M, Lee AE, Hogg A, Anderson RF, Lee HH, Siim BG, Denny WA, Wilson WR.
    J Med Chem; 2001 Oct 11; 44(21):3511-22. PubMed ID: 11585455
    [Abstract] [Full Text] [Related]

  • 5. Radiation-activated prodrugs as hypoxia-selective cytotoxins: model studies with nitroarylmethyl quaternary salts.
    Wilson WR, Tercel M, Anderson RF, Denny WA.
    Anticancer Drug Des; 1998 Sep 11; 13(6):663-85. PubMed ID: 9755724
    [Abstract] [Full Text] [Related]

  • 6. Reductive chemistry of the novel hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.
    Palmer BD, van Zijl P, Denny WA, Wilson WR.
    J Med Chem; 1995 Mar 31; 38(7):1229-41. PubMed ID: 7707325
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Optimization of the auxiliary ligand shell of Cobalt(III)(8-hydroxyquinoline) complexes as model hypoxia-selective radiation-activated prodrugs.
    Ahn GO, Ware DC, Denny WA, Wilson WR.
    Radiat Res; 2004 Sep 31; 162(3):315-25. PubMed ID: 15333003
    [Abstract] [Full Text] [Related]

  • 13. Bis(dialkyl)dithiocarbamato cobalt(III) complexes of bidentate nitrogen mustards: synthesis, reduction chemistry and biological evaluation as hypoxia-selective cytotoxins.
    Ware DC, Palmer HR, Pruijn FB, Anderson RF, Brothers PJ, Denny WA, Wilson WR.
    Anticancer Drug Des; 1998 Mar 31; 13(2):81-103. PubMed ID: 9524553
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Exploiting tumor hypoxia through bioreductive release of diffusible cytotoxins: the cobalt(III)-nitrogen mustard complex SN 24771.
    Wilson WR, Moselen JW, Cliffe S, Denny WA, Ware DC.
    Int J Radiat Oncol Biol Phys; 1994 May 15; 29(2):323-7. PubMed ID: 8195027
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Design, synthesis and evaluation of targeted hypoxia-activated prodrugs applied to chondrosarcoma chemotherapy.
    Gerard Y, Voissière A, Peyrode C, Galmier MJ, Maubert E, Ghedira D, Tarrit S, Gaumet V, Canitrot D, Miot-Noirault E, Chezal JM, Weber V.
    Bioorg Chem; 2020 May 15; 98():103747. PubMed ID: 32208207
    [Abstract] [Full Text] [Related]

  • 19. Hypoxia-dependent retinal toxicity of bioreductive anticancer prodrugs in mice.
    Lee AE, Wilson WR.
    Toxicol Appl Pharmacol; 2000 Feb 15; 163(1):50-9. PubMed ID: 10662604
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and evaluation of nitroheterocyclic carbamate prodrugs for use with nitroreductase-mediated gene-directed enzyme prodrug therapy.
    Hay MP, Anderson RF, Ferry DM, Wilson WR, Denny WA.
    J Med Chem; 2003 Dec 04; 46(25):5533-45. PubMed ID: 14640560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.